摘要
本文简要介绍了FDA对药品市场独占权的规定。并将其与中国的新药保护政策进行比较分析。就如何加强中国的新药保护提几点建议。
The authors briefly introduced FDA's regulations on new drug exclusivity and compared them with China's new drug protection policies. The authors also give some suggestions on how to improve new drug protection in China.
出处
《中国药事》
CAS
2004年第2期96-99,共4页
Chinese Pharmaceutical Affairs
关键词
新药保护
市场独占权
新药申请
new drug protection, exclusivity, new drug application